| Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. | |
| | |
MedLine Citation:
|
PMID: 11531177 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Therapy for patent foramen ovale (PFO), found with increased frequency in the setting of stroke in the young, is controversial. We compiled a synthesis of the literature on therapeutic options for PFO and stroke. METHODS: Searching MEDLINE (1966 to 1999), published abstracts, and bibliographies of primary and review articles, we identified five retrospective cohort studies that compared at least two different treatment options (antiplatelet therapy, warfarin, or surgery). Outcomes data on mode of therapy and recurrent stroke were abstracted, and pooled analysis was done using a random effects model. RESULTS: Warfarin was superior to antiplatelet therapy in preventing recurrent ischemic events (odds ratio [OR] 0.37; 95% confidence interval [CI], 0.23 to 0.60). Surgical PFO closure was comparable to warfarin treatment (OR 1.19; 95% CI, 0.62 to 2.27). CONCLUSION: Available data suggest that warfarin is superior to antiplatelet therapy and comparable to surgical PFO closure for the prevention of recurrent cerebral ischemic events from paradoxical embolism. |
| | |
Authors:
|
M A Orgera; P G O'Malley; A J Taylor |
Related Documents
:
|
3115287 - Efficacy of antiprostaglandin therapy in vernal conjunctivitis. 18413687 - Interactions between warfarin and three commonly prescribed fluoroquinolones. 1123447 - The efficacy of long-term oral anticoagulant therapy and its laboratory assessment. 19738137 - Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized c... 7633987 - Effects of spinal cord stimulation (scs) in patients with inoperable severe lower limb ... 3585887 - Blood loss associated with uncemented total hip replacement: hypotension does not affec... |
Publication Detail:
|
Type: Journal Article; Meta-Analysis |
Journal Detail:
|
Title: Southern medical journal Volume: 94 ISSN: 0038-4348 ISO Abbreviation: South. Med. J. Publication Date: 2001 Jul |
Date Detail:
|
Created Date: 2001-09-03 Completed Date: 2001-09-13 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0404522 Medline TA: South Med J Country: United States |
Other Details:
|
Languages: eng Pagination: 699-703 Citation Subset: AIM; IM |
Affiliation:
|
Cardiology and General Internal Medicine Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticoagulants / therapeutic use* Brain Ischemia* / etiology, prevention & control Heart Septal Defects, Atrial / complications* Humans Male Middle Aged Warfarin / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 81-81-2/Warfarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pemphigus in the southeastern United States.
Next Document: Reducing the incidence of sudden infant death syndrome in the Delta region of Mississippi: a three-p...